Truist Securities Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU)
Tweet Send to a Friend
Truist Securities analyst Asthika Goonewardene reiterated a Buy rating and $7.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
